Clinical Trials Logo

Filter by:
NCT ID: NCT04294719 Completed - Schizophrenia Clinical Trials

A Study of Cognitive Adaptation Training in Inpatient Forensic Environments

finCAT
Start date: December 12, 2019
Phase:
Study type: Observational

The proposed project will be a mixed-methods feasibility study of modified Cognitive Adaptation Training for an inpatient forensic mental health population (finCAT). Cognitive Adaptation Training (CAT) is an evidence-based compensatory cognitive intervention that focuses on improving functioning through the provision of environmental supports and cues. CAT is typically applied in outpatient care but has been successfully modified for inpatient service contexts in a Netherlands trial and at CAMH in previous pilots for both forensic and non-forensic inpatient populations.

NCT ID: NCT04294472 Completed - BK Virus Infection Clinical Trials

A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients

Start date: August 5, 2020
Phase: Phase 2
Study type: Interventional

This clinical research study will test the safety and efficacy of the investigational medication MAU868, compared to a placebo, in patients who have had a kidney transplant who have active BK virus.

NCT ID: NCT04294121 Completed - Food Marketing Clinical Trials

Can a Coding Tool Accurately Evaluate How Kids Respond to Marketing on Food Packaging?

Start date: May 21, 2019
Phase: N/A
Study type: Interventional

Child-appealing marketing for unhealthy foods and beverages is a global public health concern, and marketing on product packaging is one of children's top sources of exposure to this type of marketing. However, there is currently no consistent method for evaluating the extent and power of child-appealing marketing on packaging, and therefore, the child-appealing packaging (CAP) coding tool was developed. This study aims to validate this novel tool by testing if the coding tool can accurately evaluate how kids respond to marketing on food packaging. The hypothesis for this study is that the CAP tool will be able to classify and rank marketing on product packaging similarly to how children and their parents rank the same food packages. In order to test this hypothesis, children and their parents will complete an activity where they classify breakfast cereals displaying different degrees of child-appealing marketing power as "child-appealing" or "non-child-appealing" and then rank them in order of their preference. Children and parents will also complete a focus group discussion to talk about why they classified and ranked the cereals the way that they did in the previous activity. Analyses will determine how well participants classifications and rankings agree with the CAP tool's classifications and rankings.

NCT ID: NCT04293094 Completed - Clinical trials for Advanced Solid Tumors

Study of AMG 650 in Adult Participants With Advanced Solid Tumors

Start date: March 11, 2020
Phase: Phase 1
Study type: Interventional

To evaluate the safety and tolerability of AMG 650 in adult participants and to determine the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D).

NCT ID: NCT04292379 Completed - Mental Health Clinical Trials

An Innovative Model of Pediatric Acute Mental Health and Addictions Care

Start date: January 29, 2020
Phase:
Study type: Observational

The investigators will implement and evaluate an integrated, evidence-based bundle of family-centred, pediatric emergency mental health and addictions care.

NCT ID: NCT04292184 Completed - Clinical trials for End Stage Renal Disease (ESRD)

Evaluation of Thiosulfate in End Stage Renal Disease and Kidney Transplantation

Start date: March 21, 2021
Phase: Phase 1
Study type: Interventional

Kidneys retrieved from deceased donors will be randomized for conventional perfusion (University of Wisconsin: UW) with or without supplementation of thiosulfate, a major H2S metabolite, and transpl anted thereafter. Recipient's renal function will be assessed prospectively to determine if thiosulfate improves allograft function.

NCT ID: NCT04291690 Completed - Quality of Life Clinical Trials

The TARGET-EFT Randomized Clinical Trial

TARGET-EFT
Start date: March 5, 2020
Phase: N/A
Study type: Interventional

Randomized clinical trial to determine whether a multicomponent intervention will lead to improvements in mobility, self-care, mood, pain, and physical activity among frail and pre-frail older adults (as measured with the Essential Frailty Toolset; EFT) hospitalized for an acute cardiovascular illness.

NCT ID: NCT04291404 Completed - Clinical trials for Children Requiring IV Placement

Virtual Reality-based Distraction to Reduce Distress in the Pediatric Emergency Department

Start date: September 28, 2020
Phase: N/A
Study type: Interventional

Needle procedures, such as intravenous (IV) insertions, are among the most commonly performed procedures for children needing medical care. IV insertions are often a painful and stressful experience for both children and their parents/ caregivers. Pediatric pain and distress that is not adequately treated may lead to a frightened and uncooperative child, repeated IV attempts and overall frustration with care for the family and clinical team. Distraction therapy is a common psychological strategy which involves engaging children in a cognitive task or activity in order to divert attention away from painful stimuli. Given children's growing enthusiasm for novel technology, the investigators propose that an immersive virtual reality (VR) experience may provide an effective means of distraction for children undergoing IV insertions.

NCT ID: NCT04291391 Completed - Obesity Clinical Trials

The Alberta NutrIMM Study - Nutrition and Immunity

NutrIMM
Start date: September 1, 2019
Phase: N/A
Study type: Interventional

This study will investigate the effect of body weight, diet, and high blood sugar levels, under controlled feeding conditions, on immune function in individuals with and without obesity. This study will be a non-randomized, four-arm parallel group, clinical trial under controlled feeding conditions (4-week nutritional intervention using a North American-type diet). A sample size of n=128 participants will be allocated into one of the following groups: - Individuals without obesity and normoglycemia (NG) (Lean-NG) - Individuals with obesity and normoglycemia (Obese-NG) - Individuals with obesity and glucose intolerance (GI) (Obese-GI) - Individuals with obesity and type 2 diabetes (T2D) (Obese-T2D) The following outcomes will be analyzed: - Immune cell function (ex-vivo cytokine production after stimulation with mitogen and T cell proliferation); - Immune cell phenotypes; - Systemic inflammation (C-reactive protein and plasma cytokines); - Glucose, insulin, glycated hemoglobin (HbA1c), and lipids; - Fatty acids and phospholipds composition in plasma and red blood cells membrane.

NCT ID: NCT04290910 Completed - Obesity Clinical Trials

A Pilot Study Evaluating a Clinically Managed Weight Loss Program

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

This is a pilot study evaluating a clinically managed weight loss program. The program consists of a 17-week weight loss program which involves a multidisciplinary team where personalized interventions are given to participants from the team based on the participants goals.